Abel Hall LLC
PRAX icon

Abel Hall LLC’s Praxis Precision Medicines PRAX Stock Holding History

Abel Hall LLC’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$304K Buy
1,043
+24
+2% +$7.94K 0.05% 435
2026
Q2 		$341K Sell
1,019
-373
-27% -$118K 0.06% 412
2026
Q1 		$448K Buy
1,392
+360
+35% +$111K 0.1% 229
2025
Q4 		$304K Buy
+1,032
New +$192K 0.07% 327

Other funds holding PRAX

Moody Aldrich Partners
Moody Aldrich Partners Marblehead, Massachusetts $523M AUM 75.24% 1-Year Est. Return
Mutual of America Capital Management
Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return
Virginia Retirement Systems
Virginia Retirement Systems Richmond, Virginia $16.3B AUM 35.33% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Raiffeisen Bank International
Raiffeisen Bank International Vienna, Austria $8.69B AUM 38.11% 1-Year Est. Return
Oppenheimer Asset Management
Oppenheimer Asset Management New York $9.5B AUM 23.46% 1-Year Est. Return

Abel Hall LLC's PRAX Position: Q3 2026 in Review

Abel Hall LLC increased its Praxis Precision Medicines (PRAX) stake by 2.4% in Q3 2026, buying an estimated $7.94K and bringing the position to 1,043 shares worth $304K. The position accounts for 0.05% of the portfolio, ranked #435.

Abel Hall LLC first reported a position in PRAX in Q4 2025 and has held it in 4 quarters since. The position peaked at $448K in Q1 2026. 49 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.

  • Abel Hall LLC held 1,043 shares of Praxis Precision Medicines worth $304K as of Q3 2026.
  • Abel Hall LLC bought 24 Praxis Precision Medicines shares in Q3 2026, an estimated $7.94K.
  • Praxis Precision Medicines made up 0.05% of Abel Hall LLC's portfolio in Q3 2026, its #435 holding.
  • Abel Hall LLC first reported a position in Praxis Precision Medicines in Q4 2025 and has held it in 4 quarters since.
  • Abel Hall LLC's Praxis Precision Medicines position peaked at $448K in Q1 2026.
  • 49 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.

Based on Abel Hall LLC's 13F filing for Q3 2026, filed 19 Oct 2026.